Hypertension Treatment and Control in Older Adult at Tanjung Sari Public Health Center

Similar documents
Knowledge and Attitude towards Prevention and Management of Hypertension in Jatinangor Sub-district

Long-Term Care Updates

International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: Vol.8, No.8, pp , 2015


Managing hypertension: a question of STRATHE

Which antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017

Prescription Pattern of Anti-Hypertensive Drugs in Adherence to JNC- 7 Guidelines

Rationale for the use of Single Pill Combination. Yong Jin Kim, MD Seoul National University Hospital

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

JMSCR Vol 06 Issue 05 Page May 2018

Incidence of Dengue Hemorrhagic Fever Related to Annual Rainfall, Population Density, Larval Free Index and Prevention Program in Bandung 2008 to 2011

Abstract. Introduction. Volume 54 Number 1 Jan.-March, Philippine Journal of Internal Medicine. Clinical Trial

2017 High Blood Pressure Clinical Practice Guideline

In the Literature 1001 BP of 1.1 mm Hg). The trial was stopped early based on prespecified stopping rules because of a significant difference in cardi

MEDAN INTERNATIONAL CONFERENCE ON ADVANCE PHARMACEUTICAL SCIENCES 2014, NOVEMBER 3-4

Combination Therapy for Hypertension

EFFICACY & SAFETY OF ORAL TRIPLE DRUG COMBINATION OF TELMISARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN THE MANAGEMENT OF NON-DIABETIC HYPERTENSION

Hypertension in the South-East Asia Region: an overview

Characteristics of Renal Cell Carcinoma in Dr. Hasan Sadikin General Hospital Bandung,

Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences

Slide notes: References:

IMPACT OF PILL BURDEN AND SOCIO-ECONOMIC STATUS OF PATIENTS ON ADHERENCE TO PHARMACOLOGIC THERAPY IN ELDERLY

REDUCING COSTS AND IMPROVING HYPERTENSION MANAGEMENT

Update on Current Trends in Hypertension Management

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

Outcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension

By Prof. Khaled El-Rabat

Healthcare Implications of Achieving JNC 7 Blood Pressure Goals in Clinical Practice

New Clinical Trends in Geriatric Medicine. April 8, 2016 Amanda Lathia, MD, MPhil Staff, Center for Geriatric Medicine

Abbreviations Cardiology I

Pattern of Use of Anti-Hypertensive Drugs In a North Indian Tertiary Care Hospital Renu, Hema Chhabra, Anita Gupta, Neetu Sharma

When should blood pressure be lowered? Should treatment be guided by blood pressure values or total cardiovascular risk?

Characteristics of Hypertension in Children at Dr. Hasan Sadikin General Hospital Bandung in January to December 2014

JNC 8 -Controversies. Sagren Naidoo Nephrologist CMJAH

The Hypertension Clinic is a part of the Internal Medicine

Prevalence of Hypertension in Semi-Urban area of Nepal

Cardiovascular Disease Risk Factors and Blood Pressure Control in Ambulatory Care Visits to Physician Offices in the U.S.

Rationale for the use of Single Pill Combination (SPC) and Asian data of ARB/CCB SPC

Prevention of Heart Failure: What s New with Hypertension

Effect of Breadfruit Leaves Infusion on Acute Renal Failure Rat Model

The underestimated risk of

Combination therapy Giuseppe M.C. Rosano, MD, PhD, MSc, FESC, FHFA St George s Hospitals NHS Trust University of London

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)

Managing Hypertension In Heart Failure Patients In A Teaching Hospital In Ghana

47 Hypertension in Elderly

Director of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016

9/17/2015. Reference: Ruschitzka F. J Hypertens 2011;29(Suppl 1):S9-14.

A fixed-dose combination of bisoprolol and amlodipine in daily practice treatment of hypertension: Results of a noninvestigational

Prevalence, awareness of hypertension in rural areas of Kurnool

Received: / Revised: / Accepted: / Published:

Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health

The JNC 8 Guidelines: A Clinical Review

Received 24 February 2015 Revised 29 April 2015 Accepted 20 May 2015

Phase 3 investigation of aprocitentan for resistant hypertension management. Investor Webcast June 2018

Υπέρταση στις γυναίκες

Hypertension Management Controversies in the Elderly Patient

Indication as per product monograph: Indicated for the treatment of mild to moderate essential hypertension.

Blood Pressure Assessment Practices of Dental Hygienists

T. Suithichaiyakul Cardiomed Chula

Blood Pressure Targets in Diabetes

Explore the Rationale for the Dual Mechanism CCB/ARB Approach in Hypertension Management

An Epidemiological Overview

Hypertension mechanisms

The Road to Renin System Optimization: Renin Inhibitor

Comparison of coronary heart disease stratification using the Jakarta cardiovascular score between main office and site office workers

Target Blood Pressure Attainment in Diabetic Hypertensive Patients: Need for more Diuretics? Waleed M. Sweileh, PhD

Valsartan Amlodipine HCT Combination: Control To Goal. Dr. Sameh Shaheen M.B.B.Ch, MSc, MD, FESC, FSCAI. Prof of cardiology Ain Shams University

Hypertension Management Focus on new RAAS blocker. Disclosure

The prevalence of hypertension in a representative

Hypertensive Urgencies And Emergencies

DEPARTMENT OF GENERAL MEDICINE WELCOMES

The problem of uncontrolled hypertension

PREVALENCE AND LIFESTYLE DETERMINANTS OF HYPERTENSION AMONG SECONDARY SCHOOL FEMALE TEACHERS IN BASRAH

Study of Serum Uric Acid Level in Hypertension

Osama Sanad (MD) Prof. of Cardiology Benha University 2016

DECLARATION OF CONFLICT OF INTEREST. None to declare

Volume 2 Number 2 (2011)

How clinically important are the results of the large trials in hypertension?

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

Hypertension Update Background

Use of Antihypertensive Medications in Patients with type -2 Diabetes in Ajman, UAE

Primary hypertension in adults

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Effectiveness of Add-On Low-Dose Diuretics in Combination Therapy for Hypertension: Losartan/Hydrochlorothiazide vs. Candesartan/Amlodipine

RESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University

Jared Moore, MD, FACP

Hypertension Update. Aaron J. Friedberg, MD

Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension

Intrinsic Risk Factors of Falls in Elderly

University of Medicine and Pharmacy Craiova THESIS

Hypertension: Developing Fixed- Dose Combination Drugs for Treatment Guidance for Industry

New Antihypertensive Strategies to Improve Blood Pressure Control

Management of Hypertension: JNC 8 and Beyond

Hypertension is a major risk factor for

ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ

Original article: A Study of prescription pattern of antihypertensive drugs in a tertiary Care teaching hospital

The control of hypertension in the. Reaching for Aggressive Blood Pressure Goals: Role of Angiotensin Receptor Blockade in Combination Therapy REPORTS

STUDY OF DRUG UITLIZATION PATTERN OF ANTIHYPERTENSIVE DRUGS IN HYPERTENSIVE NEPHROPATHY IN A TERTIARY CARE TEACHING HOSPITAL, BAREILLY, U.P.

Egyptian Hypertension Guidelines

Introduction. Ainna Binti Mohamad Dat, 1 Tertianto Prabowo, 2 Alwin Tahid 3. Abstract

Transcription:

17 Hypertension Treatment and Control in Older Adult at Tanjung Sari Public Health Center Rahmi Fauziah, 1 Enny Rohmawaty, 2 Lazuardhi Dwipa, 3 1 Faculty of Medicine Universitas Padjadjaran 2 Department of Pharmacology and Therapy Faculty of Medicine Universitas Padjadjaran, 3 Department of Internal MedicineFaculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung Abstract Background: Hypertension is considered as a major health problem in Indonesia, especially in older adult population because of its prevalence increases by age. Treatment strategy and control management of hypertension in Public Health Center (Pusat Kesehatan Masyarakat, Puskesmas) as primary health care should be enhanced to overcome this issue. This study aimed to describe the pattern of antihypertensive agent in older adults. Methods: This was a descriptive study with total sampling method for data collection. Data were collected from medical record of older adult patients with diagnosis of hypertension at Puskesmas Tanjung Sari from January to December 2013. The variables observed were gender, number of visits, the degree of hypertension, types of antihypertensive drug, combinations of antihypertensive drugs, and blood pressure control. Results: The number of older adults with hypertension was 180 people. Some of which, 120 women (66.7%) participated, 152 (84.4%) had hypertension stage 2, 100 (55.6%) had just one visit, and 80 (44.4%) had more than one visit. Among 80 participants with more than one visit, 8 had achieved target blood pressure. There were 166 participants (92.2%) who received single antihypertensive agent (captopril was given the most), and 14 participants (7.8%) who received the combination of two antihypertensive agent (combination of captopril and HCT (hydrochlorothiazide)) were given the most). Conclusions: More than 75% of older adult with hypertension have stage 2 hypertension and are treated by single antihypertensive agent. Ninety percent of the patient have uncontrolled blood pressure. [AMJ.2016;3(1):17 21] Keywords: Antihypertensive agent, hypertension, older adult, public health center Introduction Increased life expectancy in few past century causes a continued increase of older adult population. 1 The population of older adult in the world will increase from the estimated 810 million in 2012 to 2 billion in 2020.1 The population of older adult in Indonesia is also expected to increase from 9% in 2012 to 25% in 2050. 1 Most of the causes of death in older adult in Indonesia are non-communicable diseases such as heart disease, stroke, and diabetes. 2 Hypertension is a disease that increases the risk of heart disease, stroke, and kidney disease and its prevalence increases by age. 3,4 Hypertension causes death of 8 million people worldwide each year and is included as one of the 10 major causes of death in the older adult in Indonesia. 2,3 The percentage of older adult who are treated in Public Health Center (Pusat Kesehatan Masyarakat, Puskesmas) is 29.31% in 2012. 2 The Ministry of Health made a policy aimed for Puskesmas as a primary health care to improve control and treatment management of hypertension in Indonesia. 5 The characteristics of older adults include multi morbidity and physiological changes in various organs that can affect the pharmacokinetics and pharmacodynamics of drugs, hence, older adults are at high risk of drug accumulation. 6-8 It contributes to the modification and influence the selection of drugs in the older adults. 8 Since the hypertension is one of the 10 major causes Correspondence: Rahmi Fauziah, Faculty of Medicine, Universitas Padjadjaran, Jalan Raya Bandung-Sumedang Km.21, Jatinangor, Sumedang, Indonesia, Phone: +6285864622002 Email: rahmi.fauziah31@gmail.com

18 AMJ March 2016 of death in the older adults in Indonesia, the control and treatment strategy become very important. In accordance with the background above, this study aimed to determine the treatment and control of hypertension in older adults in Puskesmas. Methods This study used descriptive study conducted at Puskesmas Tanjung Sari with total sampling method for data collection. The subject used in this study was medical record of older adult patients with diagnosis of hypertension at Puskesmas Tanjung Sari from January 1st to December 31st 2013. The instruments of this study used secondary data in the form of medical records at Puskesmas Tanjung Sari. The minimum total sample was obtained by using descriptive categorical formula with a precision of 10% which is equal to 73 samples. The distribution of frequencies and percentages were calculated using Microsoft Excel. This study was conducted after obtaining permission from The Health Research Ethics Committee Faculty of Medicine Universitas Padjadjaran Bandung. Inclusion criteria of the objects in this study were older adult patients aged 60 years who were treated at Puskesmas Tanjung Sari from January 1st to December 31st2013, with diagnosis of hypertension according to Joint National Committee 7 (JNC 7) criteria. The criteria are the results of measurement of systolic blood pressure 140 mmhg or diastolic blood pressure 90 mmhg, whether or not accompanied by other diseases and are given antihypertensive drug. Exclusion criteria of the objects in this study were patients with uncompleted medical records in the first visit. Study variables observed in this study were gender, number of visits, the degree of hypertension, types of antihypertensive drug, combinations of antihypertensive drugs, and blood pressure control. Gender of the patients was classified as male and female. The number of visits was defined as how many times the patient went to the Puskesmas to control blood pressure, and was divided into only one visit and more than one visit. The degrees of hypertension were classified based on JNC 7 criteria (normal: <120/80, prehypertension: 120 139/80 89, stage 1 hypertension: 140 159/90 99, stage 2 hypertension: 160/100) and were taken in the first visit.9 Types of antihypertensive drug and combinations of antihypertensive drugs used were taken in the first visit. Blood pressure control was taken in the last visit of the patients who had more than one visit and used the NICE clinical guideline criteria of hypertension in 2011 (age <80 years: <140/90 and age 80 years: <150/90). 10 Results During the study period from January 1st to December 31st2013, there were 41,205 patients treated at the Puskesmas Tanjung Sari according to the data obtained from the Summary Report Visit at Puskesmas Tanjung Table 1 Patient Characteristics Patient Characteristics Total (n=180) Gender Male 60 (33.3 %) Female 120 (66.7 %) Number of Visits Only 1 visit 100 (55.6 %) > 1 visit 80 (44.4%) Degrees of Hypertension Prehypertension 3 (1.7 %) Stage 1 Hypertension 25 (13.9 %) Stage 2 Hypertension 152 (84.4 %) Types of Antihypertensive Agent Single 166 (92.2 %) Combination 14 (7.8 %)

Rahmi Fauziah, Enny Rohmawaty, Lazuardhi Dwipa: Hypertension Treatment and Control in Older Adult at Tanjung Sari Public Health Center 19 Table 2 Distribution of Single Antihypertensive Agent Types of drug Total (n=166) HCT (Hydrochlorothiazide) 7 (4.2%) Reserpine 24 (14.5%) Amlodipine 3 (1.8%) Captopril 132 (79.5%) Table 3 Distribution of Combination of 2 Antihypertensive Agent Types of drug Total (n=14) Captopril + HCT 11 Captopril + Reserpine 1 Reserpine + HCT 2 Sari. Among 41,205 patients, there were 180 older adult patients with hypertension who met the inclusion and exclusion criteria that have been determined. Based on the distribution of gender, older adult patients with hypertension treated at the Puskesmas Tanjung Sari were mostly women compared to men with a ratio 2:1, who visited only one time to control the blood pressure, and had stage 2 hypertension (Table 1). The use of a single antihypertensive agent in the first visit was higher than a combinations of two antihypertensive agents. These results indicated that more than 75% of patients had stage 2 hypertension and were treated by a single antihypertensive agent. Based on the distribution of a single antihypertensive agent in the first visit (Table 2), the majority of older adult patients received captopril followed sequentially by reserpine, HCT, and amlodipine. Most of the older adult patients received combination of captopril and HCT, followed by a combination of reserpine and HCT, and the combination of captopril and reserpine (Table 3). Based on the distribution of controlled blood pressure, the result indicated that 90% of patients who had more than one visit had uncontrolled blood pressure (Table 4). Discussion The results of this study showed that women were the most of the older adults with hypertension. Several factors that cause hypertension in older women who had menopause (postmenopausal) are genetic factors, environmental and the decrease of estrogen levels that can induce endothelial dysfunction, obesity, activation of the Renin- Angiotensin-Aldosterone System (RAAS), and oxidative stress. These factors contribute to the increase of renal vasoconstriction leading to hypertension. 11 The number of older adult patients who had only one visit were more than patients who had more than one visit. The results of this study may indicate the low awareness of older adult patients to control their blood pressure. This is consistent with the study by Brindel Pauline et al. 12 that showed that the frequency of visit in older adult patients with hypertension is associated with a high percentage of awareness, treatment and control of blood pressure. But things such as the patient visit which is not recorded at the medical record, the patient changes to private doctors or other health facilities and lack of education about the importance of controlled blood pressure, can cause the likelihood of the Table 4 Distribution of Controlled Blood Pressure Blood Pressure Total (n=80) Controlled 8 (10%) Uncontrolled 72 (90 %)

20 AMJ March 2016 higher number of patient with only one visit. The majority of patients who received antihypertensive agent in the first visit had stage 2 hypertension. The results are in accordance with the recommendation of 2013 European Society of Hypertension (ESH)/European Society of Cardiology (ESC) guidelines for the Management of Arterial Hypertension that the initiation of antihypertensive drug administration in the older adult is recommended at stage 2 hypertension. 13 In this study, older adult patients with hypertension mostly received a single antihypertensive agent in their first visit. This is in accordance with AHA 2011 Expert Consensus Document on Hypertension in the Elderly that initiation of antihypertensive drug treatment in the older adult begins with a single drug administration with the lowest dose. The dose gradually increases until it reaches the maximum dose that can be tolerated depending on the response of the patient s blood pressure. However, if the blood pressure is more than 20 or 10 mmhg above the target blood pressure, the treatment should be initiated with two antihypertensive agents. 14 The results of this study showed that a single antihypertensive agent most often given in older adult was captopril. According to the 2013 European Society of Hypertension (ESH)/European Society of Cardiology (ESC) guidelines for the Management of Arterial Hypertension, all antihypertensive drugs recommended and can be used by the older adult, although diuretics and calcium antagonist is recommended in older adult patients with isolated systolic hypertension.13 Based on the interview with the doctor on duty at Puskesmas Tanjung Sari, captopril administration was most often because the availability of other antihypertensive drugs at Puskesmas Tanjung Sari was limited in 2013, while after the National Health Coverage (JKN), the availability of antihypertensive agent at Puskesmas Tanjung Sari is amlodipine (calcium antagonists). The combination of two antihypertensive drugs most frequently used in the older adults was captopril and HCT. Several studies have shown that the combination of ACE-I (Angiotensin Converting Enzyme Inhibitors) and diuretics can lower systolic blood pressure in patients with transient ischemic attack or previous stroke, diabetes, and hypertension patients aged 80 years and over. 13 Older adult patients with hypertension who achieved target blood pressure in the last visit were 90% with more than one visit. The low number of controlled blood pressure can be caused by the poor compliance. 15,16 In this study, poor compliance to antihypertensive drugs is likely affected by the lack of patient s knowledge about the importance of blood pressure control, lack of education, long term and continuous treatment. In addition, based on the data from patients medical record who listed the number of antihypertensive drugs that were given, it can be concluded that the duration of captopril administration as antihypertensive drugs were most often given in 3 or 5 days. Antihypertensive drugs that were given in small numbers caused the patient must often come back to the Puskesmas in order to get an antihypertensive drug again, hence, it may affect patients compliance. This is consistent with other studies that the factors that contribute to poor adherence to antihypertensive agent include lack of patient understanding of the importance of achieving blood pressure control, lack of education to the patient, access to health facilities, drug adverse effects, drug cost, and low socioeconomic status. 17-19 The conclusion of this study is more than 75% of older adults with hypertension have hypertension stage 2 and are treated by single antihypertensive agent (captopril), and ninety percent of the patients with more than one visit have uncontrolled blood pressure. The limitation in this study is incomplete data recorded in the medical record at Puskesmas Tanjung Sari, in the form of blood pressure data, diagnosis, and antihypertensive drugs given. Moreover, the medical recordkeeping system at Puskesmas Tanjung Sari is not good enough, so it took times when that patients data were not recorded in the medical record. It is suggested that the completeness of data in the medical record and medical record-keeping system should be improved in order to ease the monitoring and reporting of treatment and medication at Puskesmas Tanjung Sari. In addition, a primary health care providers and physicians who work in Puskesmas are expected to improve the treatment management of hypertension, especially in the older adults. Suggestion for further study is about factors that influence the number of visits and blood pressure control in older adult patients with hypertension at the Puskesmas Tanjung Sari should be conducted.

Rahmi Fauziah, Enny Rohmawaty, Lazuardhi Dwipa: Hypertension Treatment and Control in Older Adult at Tanjung Sari Public Health Center 21 References 1. Departement of Economic and Social Affairs. Population ageing and development 2012. New York: United Nations; 2012. 2. Pusat Data dan Informasi. Buletin lansia. Jakarta: Departemen Kesehatan Republik Indonesia; 2013. 3. Lawes CM, Hoorn SV, Rodgers A. Global burden of blood pressure related disease, 2001. Lancet. 2008;371(9623):1513 8. 4. Rahajeng E, Tuminah S. Prevalence of hypertension and its determinants in Indonesia. Maj Kedok Indon. 2009;59(12):580 7. 5. Departemen Kesehatan Republik Indonesia. Masalah hipertensi di Indonesia. Jakarta: 2012 [cited 2014 March 2]; Available from: http://www.depkes.go.id/ article/view/1909/masalah-hipertensidi-indonesia.html. 6. Shi S, Mörike K, Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol. 2008;64(2):183 99. 7. Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fund Clin Pharmacol. 2007;21(3):217 30. 8. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56(2):163 84. 9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560 71. 10. Krause T, Lovibond K, Caulfield M, McCormack T, Williams B. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891. 11. Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension:an age-old debate. Hypertension. 2008;51(4):952 9. 12. Brindel P, Hanon O, Dartigues J-Fo, Ritchie K, Lacombe J-M, Ducimetià re P, et al. Prevalence, awareness, treatment, and control of hypertension in the elderly: the Three City study. J Hypertens. 2006;24(1):51 8. 13. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ ESC guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159 219. 14. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, et al. ACCF/ AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2011;57(20):2037 114. 15. Bramley TJ, Gerbino P, Nightengale B, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12(3):239 45. 16. Yiannakopoulou EC, Papadopulos JS, Cokkinos DV, Mountokalakis TD. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Prev Cardiol. 2005;12(3):243 9. 17. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19(4):357 62. 18. Roumie CL, Elasy TA, Greevy R, Griffin MR, Liu X, Stone WJ, et al. Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med. 2006;145(3):165 75. 19. Baroletti S, Dell Orfano H. Medication adherence in cardiovascular disease. Circulation. 2010;121(12):1455 8.